PMC:7376974 / 13944-14379 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T56","span":{"begin":58,"end":61},"obj":"Body_part"},{"id":"T57","span":{"begin":121,"end":124},"obj":"Body_part"},{"id":"T58","span":{"begin":295,"end":302},"obj":"Body_part"},{"id":"T59","span":{"begin":397,"end":400},"obj":"Body_part"}],"attributes":[{"id":"A56","pred":"fma_id","subj":"T56","obj":"http://purl.org/sig/ont/fma/fma278683"},{"id":"A57","pred":"fma_id","subj":"T57","obj":"http://purl.org/sig/ont/fma/fma278683"},{"id":"A58","pred":"fma_id","subj":"T58","obj":"http://purl.org/sig/ont/fma/fma67257"},{"id":"A59","pred":"fma_id","subj":"T59","obj":"http://purl.org/sig/ont/fma/fma74412"}],"text":"size (nm) active concentration mechanism of action ref\nHIV-1 spherical 1–10 25 μg/mL interaction with gp120 (11)\nHIV-1 IIIB – 30–50 440 μg/mL interaction with gp120 (19)\nHSV-1, HSV-2, and HPIV-3 – 20–50 not available possible interaction directly with the viral envelope or its protein (20)\nAdenovirus type 3 spherical 5–18 25 μg/mL direct destruction of virus particles and DNA structure (15)\nH1N1 influenza A v"}

{"project":"LitCovid-PubTator","denotations":[{"id":"141","span":{"begin":109,"end":114},"obj":"Gene"},{"id":"142","span":{"begin":171,"end":176},"obj":"Gene"},{"id":"143","span":{"begin":58,"end":63},"obj":"Species"},{"id":"144","span":{"begin":121,"end":126},"obj":"Species"},{"id":"145","span":{"begin":183,"end":188},"obj":"Species"},{"id":"146","span":{"begin":190,"end":195},"obj":"Species"},{"id":"147","span":{"begin":201,"end":207},"obj":"Species"},{"id":"148","span":{"begin":309,"end":326},"obj":"Species"},{"id":"149","span":{"begin":417,"end":421},"obj":"Species"}],"attributes":[{"id":"A141","pred":"tao:has_database_id","subj":"141","obj":"Gene:3700"},{"id":"A142","pred":"tao:has_database_id","subj":"142","obj":"Gene:3700"},{"id":"A143","pred":"tao:has_database_id","subj":"143","obj":"Tax:11676"},{"id":"A144","pred":"tao:has_database_id","subj":"144","obj":"Tax:11676"},{"id":"A145","pred":"tao:has_database_id","subj":"145","obj":"Tax:10298"},{"id":"A146","pred":"tao:has_database_id","subj":"146","obj":"Tax:10310"},{"id":"A147","pred":"tao:has_database_id","subj":"147","obj":"Tax:11216"},{"id":"A148","pred":"tao:has_database_id","subj":"148","obj":"Tax:45659"},{"id":"A149","pred":"tao:has_database_id","subj":"149","obj":"Tax:114727"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"size (nm) active concentration mechanism of action ref\nHIV-1 spherical 1–10 25 μg/mL interaction with gp120 (11)\nHIV-1 IIIB – 30–50 440 μg/mL interaction with gp120 (19)\nHSV-1, HSV-2, and HPIV-3 – 20–50 not available possible interaction directly with the viral envelope or its protein (20)\nAdenovirus type 3 spherical 5–18 25 μg/mL direct destruction of virus particles and DNA structure (15)\nH1N1 influenza A v"}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T31","span":{"begin":417,"end":431},"obj":"Disease"},{"id":"T32","span":{"begin":422,"end":431},"obj":"Disease"}],"attributes":[{"id":"A31","pred":"mondo_id","subj":"T31","obj":"http://purl.obolibrary.org/obo/MONDO_0005460"},{"id":"A32","pred":"mondo_id","subj":"T32","obj":"http://purl.obolibrary.org/obo/MONDO_0005812"}],"text":"size (nm) active concentration mechanism of action ref\nHIV-1 spherical 1–10 25 μg/mL interaction with gp120 (11)\nHIV-1 IIIB – 30–50 440 μg/mL interaction with gp120 (19)\nHSV-1, HSV-2, and HPIV-3 – 20–50 not available possible interaction directly with the viral envelope or its protein (20)\nAdenovirus type 3 spherical 5–18 25 μg/mL direct destruction of virus particles and DNA structure (15)\nH1N1 influenza A v"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T124","span":{"begin":11,"end":17},"obj":"http://purl.obolibrary.org/obo/CLO_0001658"},{"id":"T125","span":{"begin":117,"end":119},"obj":"http://purl.obolibrary.org/obo/CLO_0053733"},{"id":"T126","span":{"begin":341,"end":343},"obj":"http://purl.obolibrary.org/obo/CLO_0050510"},{"id":"T127","span":{"begin":377,"end":382},"obj":"http://purl.obolibrary.org/obo/NCBITaxon_10239"},{"id":"T128","span":{"begin":432,"end":433},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"}],"text":"size (nm) active concentration mechanism of action ref\nHIV-1 spherical 1–10 25 μg/mL interaction with gp120 (11)\nHIV-1 IIIB – 30–50 440 μg/mL interaction with gp120 (19)\nHSV-1, HSV-2, and HPIV-3 – 20–50 not available possible interaction directly with the viral envelope or its protein (20)\nAdenovirus type 3 spherical 5–18 25 μg/mL direct destruction of virus particles and DNA structure (15)\nH1N1 influenza A v"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T113","span":{"begin":295,"end":302},"obj":"Chemical"},{"id":"T114","span":{"begin":397,"end":400},"obj":"Chemical"}],"attributes":[{"id":"A113","pred":"chebi_id","subj":"T113","obj":"http://purl.obolibrary.org/obo/CHEBI_36080"},{"id":"A114","pred":"chebi_id","subj":"T114","obj":"http://purl.obolibrary.org/obo/CHEBI_16991"}],"text":"size (nm) active concentration mechanism of action ref\nHIV-1 spherical 1–10 25 μg/mL interaction with gp120 (11)\nHIV-1 IIIB – 30–50 440 μg/mL interaction with gp120 (19)\nHSV-1, HSV-2, and HPIV-3 – 20–50 not available possible interaction directly with the viral envelope or its protein (20)\nAdenovirus type 3 spherical 5–18 25 μg/mL direct destruction of virus particles and DNA structure (15)\nH1N1 influenza A v"}

{"project":"LitCovid-sentences","denotations":[{"id":"T90","span":{"begin":58,"end":120},"obj":"Sentence"},{"id":"T91","span":{"begin":121,"end":182},"obj":"Sentence"},{"id":"T92","span":{"begin":183,"end":308},"obj":"Sentence"},{"id":"T93","span":{"begin":309,"end":416},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"size (nm) active concentration mechanism of action ref\nHIV-1 spherical 1–10 25 μg/mL interaction with gp120 (11)\nHIV-1 IIIB – 30–50 440 μg/mL interaction with gp120 (19)\nHSV-1, HSV-2, and HPIV-3 – 20–50 not available possible interaction directly with the viral envelope or its protein (20)\nAdenovirus type 3 spherical 5–18 25 μg/mL direct destruction of virus particles and DNA structure (15)\nH1N1 influenza A v"}

{"project":"2_test","denotations":[{"id":"32667191-23886562-153271","span":{"begin":413,"end":415},"obj":"23886562"}],"text":"size (nm) active concentration mechanism of action ref\nHIV-1 spherical 1–10 25 μg/mL interaction with gp120 (11)\nHIV-1 IIIB – 30–50 440 μg/mL interaction with gp120 (19)\nHSV-1, HSV-2, and HPIV-3 – 20–50 not available possible interaction directly with the viral envelope or its protein (20)\nAdenovirus type 3 spherical 5–18 25 μg/mL direct destruction of virus particles and DNA structure (15)\nH1N1 influenza A v"}